<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for FOLD</title>
    <link />
    <description>Headlines for Amicus Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/markets/bonds/13/06/3682497/market-wrap-for-tuesday-june-17-stocks-jump-to-start-trading-week-dow-ra.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Jun 2013 16:21:39 GMT</pubDate>
    </item>
    <item>
      <title>Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/market-wrap-for-tuesday-june-17-stocks-jump-to-start-trading-week-dow-rallies-triple-digits-cm253756.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 17 Jun 2013 16:21:39 GMT</pubDate>
    </item>
    <item>
      <title>Market Wrap for Monday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/market-wrap-for-monday-june-17-stocks-jump-to-start-trading-week-dow-rallies-triple-digits-cm253756.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 17 Jun 2013 16:21:39 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics' CEO Presents at Fabry Monotherapy Strategic Update Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1506462-amicus-therapeutics-ceo-presents-at-fabry-monotherapy-strategic-update-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 16:17:06 GMT</pubDate>
    </item>
    <item>
      <title>Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains Until Fed Chatter Cools Buye</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/06/17/closing-bell-for-monday-on-wall-street-markets-open-higher-hold-gains-until-fed-chatter-cools-buyers/.aspx</link>
      <author>247wallst</author>
      <pubDate>Mon, 17 Jun 2013 16:06:31 GMT</pubDate>
    </item>
    <item>
      <title>Afternoon Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3681723/afternoon-market-losers.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Jun 2013 12:29:04 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics Delays Seeking OK For Fabry Drug, Shares Fall</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130617-000197&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 17 Jun 2013 10:52:59 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Delays U.S. Approval Filing for Fabry Disease Drug</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11951746/1/amicus-delays-us-approval-filing-for-fabry-disease-drug.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 17 Jun 2013 08:43:00 GMT</pubDate>
    </item>
    <item>
      <title>These 2 Biotechs May Surprise Investors, Says Janney Analyst Kimberly Lee</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1496992-these-2-biotechs-may-surprise-investors-says-janney-analyst-kimberly-lee.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 12 Jun 2013 11:23:12 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: 2013 Clinical Trials Calendar</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11943871/1/biotech-stock-mailbag-2013-clinical-trials-calendar.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 07 Jun 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Commit To Buy Amicus Therapeutics At $2.50, Earn 25.9% Annualized</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11938658/1/commit-to-buy-amicus-therapeutics-at-250-earn-259-annualized.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 31 May 2013 13:53:00 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1451841-amicus-therapeutics-ceo-presents-at-2013-ubs-global-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 19:14:07 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics: The Good And The Bad</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1437011-amicus-therapeutics-the-good-and-the-bad.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 13:31:30 GMT</pubDate>
    </item>
    <item>
      <title>Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/insm/articles/186537/significant-near-term-top-line-data-catalyst-and-platform-technology-should-rally-insmed/2013-05-14.aspx</link>
      <author>Trefis</author>
      <pubDate>Tue, 14 May 2013 10:39:21 GMT</pubDate>
    </item>
    <item>
      <title>Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431661-significant-near-term-top-line-data-catalyst-and-platform-technology-should-propel-insmed.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 10:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Amicus' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1422841-amicus-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 00:46:06 GMT</pubDate>
    </item>
    <item>
      <title>Curing Parkinson's: The Alternative Approach - Is There Money To Be Made?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1320381-curing-parkinson-s-the-alternative-approach-is-there-money-to-be-made.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 04 Apr 2013 09:29:13 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1268891-amicus-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Mar 2013 22:47:01 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for March 12, 2013 :  KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN,</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx-fold-gcap-cm226423.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 12 Mar 2013 14:00:05 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics Unveils Proprietary "CHART" Platform Technology</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3385437/amicus-therapeutics-unveils-proprietary-chart-platform-technology.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 04 Mar 2013 07:45:25 GMT</pubDate>
    </item>
  </channel>
</rss>
